Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration

Retrieved on: 2025-09-06 12:05:00

Tags for this article:

Click the tags to see associated articles and topics

Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration. View article details on hiswai:

Excerpt

Basel: Roche has announced that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as ...

Article found on: medicaldialogues.in